NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP) today announced its operating results for the third quarter ended September 30, 2011.
Service revenue for the third quarter of 2011 was $1,021,000, compared to $676,000 in the third quarter of 2010. Service revenue for the first nine months of 2011 was $2.7 million, compared to $2.3 million for the first nine months of 2010. The increase in revenue is from contracts relating to the Company’s cervical cancer detection technology and Biofield co-development agreement.
Service revenue for the third quarter of 2011 was $1,021,000, compared to $676,000 in the third quarter of 2010. Service revenue for the first nine months of 2011 was $2.7 million, compared to $2.3 million for the first nine months of 2010. The increase in revenue is from contracts relating to the Company’s cervical cancer detection technology and Biofield co-development agreement.
